Application of Recombinant and Non-Recombinant Peptides in the Determination of Tumor Response to Cancer Therapy

E-ISSN： 1873-4316|12|2|320-335

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.12, Iss.2, 2011-02, pp. : 320-335

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recombinant antibodies: a novel approach to cancer diagnosis and therapy

By Hudson P.J.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 6, 2000-06 ,pp. : 1231-1242

Informa Healthcare

Access to resources Recommend Favorite

Recombinant proteins for therapy

By Buckel P.

Trends in Pharmacological Sciences, Vol. 17, Iss. 12, 1996-12 ,pp. : 450-456

Elsevier

Access to resources Recommend Favorite

Antibody Engineering for Targeted Therapy of Cancer Recombinant Fv-Immunotoxins

Current Pharmaceutical Biotechnology, Vol. 2, Iss. 1, 2001-03 ,pp. : 19-46

Bentham Science Publishers

Access to resources Recommend Favorite

Intraperitoneal Oncolytic and Tumor Vaccination Therapy with Replication-Competent Recombinant Virus: The Herpes Paradigm

Current Gene Therapy, Vol. 3, Iss. 2, 2003-04 ,pp. : 113-125

Bentham Science Publishers

Access to resources Recommend Favorite

Peptides-Staple Method Development and Its Application in Cancer Therapy

Current Medicinal Chemistry, Vol. 21, Iss. 21, 2014-07 ,pp. : 2438-2452

Bentham Science Publishers

Access to resources Recommend Favorite